Results: 2

Fig 2.

Fig 2. From: Multicenter Phase II Trial of Neoadjuvant Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy and Radiation for Malignant Pleural Mesothelioma.

(A) Kaplan-Meier overall survival, intent-to-treat (ITT) population (median, 16.8 months; 95% CI, 3.6 to 23.2 months). (B) Kaplan-Meier progression-free survival, ITT population (median, 10.1 months; 95% CI, 8.6 to 15.0 months).

Lee M. Krug, et al. J Clin Oncol. 2009 June 20;27(18):3007-3013.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk